Parents' Perceptions of Novel Treatments for Child and Adolescent Specific Phobia and Anxiety Disorders.
This study aimed to examine parents' perceptions of established treatments, including cognitive behaviour therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs), relative to novel treatments of D-cycloserine (DCS) and attention bias modification (ABM) augmented CBT to determine if novel treatments are perceived as more or less favorable than established treatments. Participants included parents of children with a specific phobia, enrolled in one of two randomized controlled trials of either one-session augmented DCS (n = 38, Gold Coast) or ABM augmented one-session treatment (n = 34, Brisbane), as well as parents from a community sample (n = 38). Parents of children with a specific phobia perceived CBT most favorably. There was no difference between the sites on perceptions of ABM. However, parents of children enrolled in the DCS trial perceived DCS more favorably than parents of children enrolled in the ABM trial and the community sample. These results demonstrate parents' greater acceptance of psychological treatments over pharmacological treatments for the treatment of childhood phobias, highlighting the importance of educating parents to novel treatments.
School of Applied Psychology and Menzies Health Institute QLD, Griffith University, Gold Coast Campus, Southport, QLD, 4222, Australia.
Carly L
CL
Roberts
School of Applied Psychology and Menzies Health Institute QLD, Griffith University, Gold Coast Campus, Southport, QLD, 4222, Australia. l.farrell@griffith.edu.au.
Lara J
LJ
Farrell
School of Applied Psychology and Menzies Health Institute, Griffith University, Mount Gravatt Campus, Mount Gravatt, QLD, 4122, Australia.
Allison M
AM
Waters
School of Applied Psychology and Menzies Health Institute QLD, Griffith University, Gold Coast Campus, Southport, QLD, 4222, Australia.
Ella L
EL
Oar
Child Study Centre, Department of Psychology, Virginia Polytechnic Institute and State University, Blacksburg, VA, 24060, USA.
Thomas H
TH
Ollendick
D000293:Adolescent; D001008:Anxiety Disorders / Q000523:psychology / Q000628:therapy*; D000070379:Attentional Bias; D001521:Behavior Therapy / Q000379:methods*; D002648:Child; D015928:Cognitive Behavioral Therapy / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D010290:Parents; D010465:Perception; D010698:Phobic Disorders / Q000523:psychology / Q000628:therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
D017367:Selective Serotonin Reuptake Inhibitors
Childhood anxiety disorders; Cognitive behaviour therapy; Pharmacotherapy; Specific phobia